Solari Alessandra, Veronese Simone, Verde Giulia Dalla, De Panfilis Ludovica, Bertocchi Elisabetta, Lissoni Barbara, Merli Rossella, Salmaggi Andrea, Silvani Antonio, Rudà Roberta, Pace Andrea
Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy.
Palliative Care and Research Department, Fondazione FARO, Turin, Italy.
Neurol Sci. 2023 May;44(5):1749-1754. doi: 10.1007/s10072-022-06593-9. Epub 2023 Jan 4.
In 2017, the European Association of Neuro-Oncology (EANO) published the guideline for palliative care in adults with glioma. The Italian Society of Neurology (SIN), the Italian Society for Palliative Care (SICP), and the Italian Association for Neuro-Oncology (AINO) joined forces to update the guideline, and adapt it to the Italian context.
We involved patients, caregivers, and (herein presented) healthcare professionals (HPs) in the formulation of the guideline clinical questions.
Online survey of Italian HPs experienced in the care of patients with glioma. Participants rated the importance of 14 pre-specified intervention topics on a 0/10 scale and gave their free comments.
Of 244 participants, 149 (61%) were palliative medicine (PM) HPs and 95 Neuro HPs. Their mean age was 48.9 years, 63% were women, and 48% had over 12 years of experience in the care of glioma patients. Physicians were 68%, followed by nurses (28%), psychologists (7%), therapists (3%), and social workers (2%). Most HPs rated the pre-specified topics as important (score ≥ 7) or critical (score ≥ 9), with some differences between PM and Neuro HP groups. There were 58 free comments: 46 (78%) on nine pre-specified topics, and 13 on four new topics, three of which were guideline-pertinent ("caregiver's support and education"; "family physician's training in neuro-oncology"; and "PM HPs' training in neuro-oncology").
Participation in the survey was high and information-rich, between-group rating differences reflecting HP background. Participants endorsed the 14 intervention topics devised by the guideline panel and identified three additional topics.
2017年,欧洲神经肿瘤学会(EANO)发布了成人胶质瘤姑息治疗指南。意大利神经病学会(SIN)、意大利姑息治疗学会(SICP)和意大利神经肿瘤协会(AINO)联合更新了该指南,使其适用于意大利的情况。
我们让患者、护理人员以及(本文介绍的)医疗保健专业人员(HPs)参与指南临床问题的制定。
对有胶质瘤患者护理经验的意大利HPs进行在线调查。参与者对14个预先指定的干预主题的重要性进行0/10评分,并给出自由评论。
244名参与者中,149名(61%)是姑息医学(PM)HPs,95名是神经科HPs。他们的平均年龄为48.9岁,63%为女性,48%有超过12年的胶质瘤患者护理经验。医生占68%,其次是护士(28%)、心理学家(7%)、治疗师(3%)和社会工作者(2%)。大多数HPs将预先指定的主题评为重要(评分≥7)或关键(评分≥9),PM和神经科HP组之间存在一些差异。有58条自由评论:46条(78%)针对9个预先指定的主题,13条针对4个新主题,其中3条与指南相关(“护理人员的支持与教育”;“家庭医生的神经肿瘤学培训”;以及“PM HPs的神经肿瘤学培训”)。
调查参与度高且信息丰富,组间评分差异反映了HP背景。参与者认可指南小组设计的14个干预主题,并确定了另外3个主题。